doi: 10.1056/NEJMp1809358.
Limiting State Flexibility in Drug Pricing
Affiliations
- PMID: 30207910
- DOI: 10.1056/NEJMp1809358
Item in Clipboard
Limiting State Flexibility in Drug Pricing
N Engl J Med.
.
No abstract available
Similar articles
-
Will Courts Allow States to Regulate Drug Prices?N Engl J Med. 2018 Sep 13;379(11):1000-1002. doi: 10.1056/NEJMp1805432. Epub 2018 Aug 8. N Engl J Med. 2018. PMID: 30088965 No abstract available.
-
Legal Challenges to State Drug Pricing Laws.JAMA. 2018 Mar 6;319(9):865-866. doi: 10.1001/jama.2017.20952. JAMA. 2018. PMID: 29435585 No abstract available.
-
States on the Front Line: Addressing America's Drug Pricing Problem.J Leg Med. 2019 Apr-Jun;39(2):81-93. doi: 10.1080/01947648.2019.1645544. J Leg Med. 2019. PMID: 31503529 No abstract available.
-
Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.J Leg Med. 2003 Jun;24(2):141-73. doi: 10.1080/713832157. J Leg Med. 2003. PMID: 12775406 Review. No abstract available.
-
Exploring options for improving healthcare.Am Heart J. 2004 Jan;147(1):23-30. doi: 10.1016/j.ahj.2003.09.006. Am Heart J. 2004. PMID: 14691414 Review.
Cited by
-
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits.J Health Polit Policy Law. 2022 Dec 1;47(6):673-690. doi: 10.1215/03616878-10041107. J Health Polit Policy Law. 2022. PMID: 35867545 Free PMC article.
-
Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval.JAMA Health Forum. 2021 Oct 8;2(10):e213177. doi: 10.1001/jamahealthforum.2021.3177. eCollection 2021 Oct. JAMA Health Forum. 2021. PMID: 35977163 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
